Recombinant Human MIP-3 beta (CCL19)

Recombinant Human MIP-3 beta (CCL19)

• Description: CCL19 is a chemokine that belongs to the CC family of growth factors and signals through the CCR7 receptor. CCl19 has been shown to be expressed in the thymus, lymph nodes and in activated bone marrow stromal cells. When anti-inflammatory signals are released, expression of CCL19 gets down-regulated – specifically by IL-10.
• CAS Number: 9000-83-3
• Gene Name: CCL19
• Gene Aliases: MIP-3-beta, C-C motif chemokine 19, MIP3, Beta-chemokine exodus-3, CK beta-11, Epstein-Barr virus-induced molecule 1 ligand chemokine, EBI1 ligand chemokine, ELC, Small-inducible cytokine A19, Exodus-3
  Recombinant Human Macrophage Inflammatory Protein-3 Beta (CCL19)
• Gene ID: 6363
• Accession Number: Q99731
• Organism: Human
• Source: E. coli
• Concentration: <1.0 EU/μg of recombinant protein as determined by the LAL method.
• Purity: >95% as determined by SDS-PAGE
• Solubility: A quick spin of the vial followed by reconstitution in sterile distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.
• Function: Measured by its ability to chemoattract 5 ­ 10 day cultured human peripheral blood lymphocytes (PBL). The ED(50) for this effect is typically 0.1­0.3 µg/mL.
• Molecular Weight: 9.1
• Shipping Conditions: Ambient Temperature
• Storage Conditions: The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.
• Appearance: Lyophilized Powder
• Formulation: Lyophilized from a 0.2 μm filtered solution containing no additives